TYROBP and Parkinson disease: While the signaling pathways involved in DAP12-mediated inhibition have not been completely understood yet [8], [9], the relationship between inflammation and neuro-degeneration for a number of disorders, including Multiple Sclerosis (MS); Alzheimer’s Disease (AD) and Parkinson’s Disease (PD), is gradually emerging [10].